However, both untreated pre-B and pre-T leukemic blasts seem to express lower levels of CD52 than their healthy mature counterparts at the time of diagnosis [102], suggesting that CD52 expression is not a common feature of ALL and might be restricted to more mature subtypes. This evidence concerns the gene CD52 and acute lymphoblastic leukemia.